Company Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye.
The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.
It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists.
The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally.
STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
| Country | United States |
| Founded | 1982 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 1,115 |
| CEO | Thomas G. Frinzi |
Contact Details
Address: 1911 Walker Ave Monrovia, California 91016 United States | |
| Phone | (626) 303-7902 |
| Website | staar.com |
Stock Details
| Ticker Symbol | STAA |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000718937 |
| CUSIP Number | 852312305 |
| ISIN Number | US8523123052 |
| Employer ID | 95-3797439 |
| SIC Code | 3851 |
Key Executives
| Name | Position |
|---|---|
| Thomas G. Frinzi | President, Chief Executive Officer and Chairman |
| Patrick F. Williams | Chief Financial Officer |
| Dr. Keith Holliday Ph.D. | Chief Technology Officer |
| James Francese | Senior Vice President of Commercial Operations - North America and APAC |
| Dr. Scott D. Barnes M.D. | Chief Medical Officer |
| Warren Foust | Chief Operating Officer |
| Brian Moore | Vice President of Investor Relations and Corporate Development |
| Samuel J. Gesten | Chief Legal Officer and Corporate Secretary |
| Dr. Magda Michna Ph.D. | Chief Clinical, Regulatory and Medical Affairs Officer |
| Robert Studholme | Senior Vice President of Operations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 4, 2024 | 8-K | Current Report |
| Mar 18, 2024 | 8-K | Current Report |
| Mar 15, 2024 | UPLOAD | Filing |
| Mar 12, 2024 | 8-K | Current Report |
| Feb 28, 2024 | 8-K | Current Report |
| Feb 27, 2024 | 10-K | Annual Report |
| Feb 26, 2024 | 8-K | Current Report |
| Feb 15, 2024 | UPLOAD | Filing |
| Feb 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Jan 26, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |